Delivery Order SPE2DB25D3404-SPE2DB25FULUG
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $6,794.48. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 9, 2024. The contract was not set aside for any specific business type. AmerisourceBergen...
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 mL) to the Defense Logistics Agency (DLA). The $5,773.01 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 11, 2024 and was awarded on October 10, 2024. This is a delivery order contract without any set-aside requirements, indicating open competition. AmerisourceBergen holds...
The federal contract award is for the delivery of GARDASIL 9 syringes (0.5ML) by Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $9,823.42 and a completion date of September 4, 2024. This is a delivery order contract with a firm fixed price. The contract is not designated as a set-aside. Amerisourcebergen has been awarded numerous federal contracts, including an Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of GARDASIL 9 syringes, 0.5 ml each, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,107.19 and an ultimate completion date of May 3, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 ml) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $33,528.10 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 14, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 15, 2024. This contract is not designated as a set-aside and is part of a larger...
This federal contract award is for the delivery of GARDASIL 9 syringes to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,568.50 and is a delivery order contract with a firm-fixed price pricing type. The award date is November 4, 2024, and the ultimate completion date is November 5, 2024. The...
This federal contract award is for the delivery of GARDASIL 9 SYRINGE 0.5ML to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $14,162.95 and is a Firm Fixed Price Delivery Order. It does not have a set-aside designation. This contract award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award is for the delivery of GARDASIL 9 vaccine syringes to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 27, 2024, with a ceiling value of $8,362.00 and a completion date of December 30, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of GARDASIL 9 vaccine syringes (0.5mL) to the Defense Logistics Agency (DLA). The $8,433.22 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 ml) to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $12,697.72, was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 31, 2025, with a completion date of February 3, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...